Introduction {#sec1-1}
============

The prevalence of diabetes mellitus (DM) is surprisingly increasing in the past 30 years; it is becoming a global epidemic major health issue.\[[@ref1]\] In 2040, the estimated number of diabetic patients may reach 642 million people worldwide, and most of the cases will be type two diabetes (T2DM).\[[@ref2]\]

Diabetes is a chronic illness that happens when the pancreas is no longer able to synthesize insulin, or when our body is unable to make good use of the insulin that it has been produced, or sometimes both combined.\[[@ref3]\] The American Diabetes Association categorizes diabetes as insulin dependent, ketosis-prone diabetes, non-insulin dependent, and diabetes caused by other disease conditions, and gestational diabetes.\[[@ref4]\]

Based on the pathophysiological mechanisms involved in its onset, it could be inferred that diabetes is usually characterized by high glucose levels, and that insulin remains a vital therapy option in many types once diagnosed. It must be noted therefore that diabetes tends to be progressive, causing multi-organ damage, and is usually accompanied by other disorders, leading to end-organ damage, termed co-morbidities.\[[@ref5]\]

In therapy options for the management of diabetes, insulin treatment was first introduced in 1922, is always indicated in autoimmune type 1 diabetes. Insulin treatment in type 2 diabetes is shown in different conditions, including the setting of ketoacidosis, latent autoimmune diabetes, symptoms of hyperglycemia and failure of non-insulin therapies because of contraindications or adverse effects.\[[@ref5]\]

The management of diabetes, like many chronic conditions, is such that it seeks to minimize the impact of the disorder especially on the physical and psychological aspect. This brings to the fore issues such as compliance, adherence, treatment markers, diet modification, lifestyle changes, literacy, location, and regular clinic appointments. Adherence and compliance are two similar terms used quite interchangeably, but adherence tends to imply patient agreement with therapy, and then compliance is simply following the laid down procedure. According to the World Health Organization (WHO), medication adherence is defined as "the degree to which the person\'s behavior corresponds with the agreed recommendations from a health care provider".\[[@ref6]\] The non-adherent patients are those whose health-seeking or maintenance behaviors lack consistency with the advice recommended or prescribed by their healthcare provider.\[[@ref7]\]

Non-adherence to medication is classified into three categories; primary non-adherence, where a medication regimen though prescribed isn't filled; non-persistence non-adherence describes a situation in which patients stop taking medications after starting without being told to do so. On the other hand, non-conforming adherence describes situations where drugs are not taken as prescribed.\[[@ref8]\]

Patient\'s non-adherence is a significant health concern that poses a hard challenge to achieve our goals in treating and preventing diabetes mellitus complications; it is widespread and has been reported from all over the world.\[[@ref7]\] Patient non-adherence is not only focused on medications, but also the inability to make lifestyle changes, undergo tests or keep appointments with their health care providers. The non-adherent patients, especially with diabetes mellitus, have been shown to have a higher incidence of severe complications with unwanted difficulties.\[[@ref9]\]

There have been several reports, studies and efforts to improve patient adherence. Notably, the American Diabetes Association categorizes the barriers to adherence as either patient barriers, medication factors, or system factors. The patient-physician relationship had played a significant rule in affecting the compliance and following the physician\'s advice.\[[@ref10]\] Patient barriers include difficulty remembering to get refills from the clinician or to pick them up from the pharmacy, trouble remembering to take medications, fear of making medications, depression, or health beliefs regarding medications. Medication regimen complexity, multiple daily dosing of drugs, cost, and side effects are all medication factors that may be barriers to adherence. System factors include inadequate follow-up and support.\[[@ref11]\]

Adherence rates to insulin therapy has been estimated to be above average at best, going at a rate of 61%.\[[@ref12]\] Sex has been proven to be a factor, though this study will investigate this further, as females tend to have slightly lower cases of non-adherence than males with 65.45% to 69.34%. Also, in a primary healthcare (PHC) centre in Al-Hasa region in Saudi Arabia, there was a significant difference between rural participants and urban participants pointing to more compliance in urban patients.\[[@ref10]\]

Common factors identified as barriers to patient adherence to insulin in diabetes patients include injection site reactions, fear of hypoglycemia, time-consuming, interference with physical activity, and lack of adequate injection instruction.\[[@ref11]\] Specifically, the following factors have been posited to have a role to play in reduced adherence inn patients with diabetes: younger age, smoking, lower socioeconomic status, lack of family support, lower educational status, other chronic diseases, concurrent medication use, and a previous poor experience with medication.\[[@ref13][@ref14][@ref15][@ref16]\]

Methods {#sec1-2}
=======

Study population {#sec2-1}
----------------

Saudi Arabian male and female diabetic patients over the age of 14 years, placed on insulin injection therapy, were selected among patients attending family medicine department, diabetic care centre, and security forces hospital in Riyadh.

Sampling technique {#sec2-2}
------------------

A convenient sampling technique was used in this study.

Study design {#sec2-3}
------------

A questionnaire was designed to cover these categories as earlier mentioned. (Patient-related factors, socioeconomic factors, condition related, health system, and therapy related barriers). The questionnaire was designed to contain 18 questions and was validated by pre-testing. The questionnaire was self-administered and retrieved.

Sample size {#sec2-4}
-----------

Using convenient sampling with a margin of error set at 5%, confidence level 95%, with a set prevalence from literature at 60%, the sample size was set at 336. Calculating for a 15% non-response rate, the final sample size was calculated at 387.

Using the formula: *n* = (z\^2 *P* (1-p))/d\^2

Where *n* = sample size, z = z statistic for the level of confidence, *P* = expected prevalence and d = allowable error. This formula assumes that 'P' and 'd' are decimal values.

Study area {#sec2-5}
----------

The study area used for this assessment was the family medicine department diabetic care centre Security Forces Hospital, Riyadh.

Duration of study {#sec2-6}
-----------------

1^st^ May--1^st^ June, 2018.

Sampling technique {#sec2-7}
------------------

### Inclusion criteria {#sec3-1}

The following criteria were used to determine participants for the study.

Male and female.Age group above 14.Type 1 diabetic patients on basal-bolus regimen.Type 2 diabetic patients on OHD and insulin regimen.Type 2 diabetic patients on insulin regimen only.Self-administering injections only.

### Exclusion criteria {#sec3-2}

Age below 14 (pediatrics).Non diabetic population.Diabetic patients on OHD only.Non self-administering diabetic patients.Mentally retarded or mentally challenged diabetic patients on insulin regimen.Gestational diabetes.

Questionnaire: A sample of the questionnaire used for the study is attached in the appendix.

The questionnaire used were filled by a trained diabetic educator of the diabetic care center in the Security Forces Hospital, Riyadh. The information was gathered via a direct personal interview with each of the patients.

Statistical analysis {#sec2-8}
--------------------

Statistical analysis was performed by SPSS, Version 20.0 (Chicago, IL, USA). Qualitative statistics had expressed as a percentage at the level of accepted as \< 0.05 for significance value. Multinomial logistic regression analysis was carried out on the adherence to insulin dose to identify the limitations that relate to poor adherence.

Results {#sec1-3}
=======

This section expresses the data obtained and presents the result in evaluating adherence to basal bolus insulin therapy.

Respondents demographics {#sec2-9}
------------------------

The demographic characteristics of the study population are present in [Table 1](#T1){ref-type="table"}. Out of 399 diabetic subjects, 202 were females (50.63%) and 197 were males (49.37%). Out of the total participants, 39.10% of the patients were in the age group 45-60. The study participants were grouped according to the education level - such as Illiterate, primary school, secondary school, high school, college/university and post-graduation study \[[Figure 1](#F1){ref-type="fig"}\]. Out of 399 subjects, 163 (40.85%) had associated chronic diseases like hypertension 59 (14.79%) had thyroid disorder, 206 (51.63) had hypercholestemia. Out of 399 subjects, 69.67% had diabetes for a period of more than 10 years of duration, 39.85% were taking 4 injections per day, and 22.31% of the patients were taking 3 injections per day.

###### 

Demographic information of respondents

  Variable                             Sub variable               Total number - 399 (%)
  ------------------------------------ -------------------------- ------------------------
  Gender                               Male                       197 (49.37)
  Female                               202 (50.63)                
  Age (Years)                          14-29                      73 (18.30)
  30-44                                60 (15.04)                 
  45-60                                156 (39.10)                
  \>60                                 110 (27.57)                
  Education Level                      Illiterate                 149 (37.34)
  Primary School                       24 (6.02)                  
  Secondary School                     47 (11.78)                 
  High School                          99 (24.81)                 
  College/university                   76 (19.05)                 
  Post-Graduation Study                4 (1)                      
  Type of Diabetes                     Type 1 Diabetes            86 (21.55)
  Type 2 Diabetes                      77 (19.30)                 
  I don't know                         236 (59.15)                
  Diabetes                                                        274 (68.67)
  Hypertension                                                    163 (40.85)
  Thyroid Disorder                                                59 (14.79)
  Hypercholestemia                                                206 (51.63)
  Other Complication                                              45 (11.28)
  Duration of Diabetes (years)         \<2                        23 (5.76)
  2-5                                  32 (8.02)                  
  5-8                                  27 (6.77)                  
  8-10                                 39 (9.77)                  
  \>10                                 278 (69.67)                
  Clinic attendance in the last year   never missed appointment   241 (60.40)
  missed 1-2 appointments              74 (18.55)                 
  Missed \>2 appointment               20 (5.01)                  
  Didn't got appointment               64 (16.04)                 
  Number of Daily injections           2                          151 (37.84)
  3                                    89 (22.31)                 
  4                                    159 (39.85)                
  Missed Dose                                                     154 (38.60)
  How many missed Dose (Dose)          1-2                        71 (17.79)
  3                                    45 (11.28)                 
  4-6                                  18 (4.51)                  
  \>6                                  18 (4.51)                  
  Never miss                           247 (61.90)                

![Gender wise age group distribution](JFMPC-8-1964-g001){#F1}

Respondents adherence to daily insulin {#sec2-10}
--------------------------------------

The response of the patients was stratified according to the demographic information and educational levels. The results were then subjected to regression analysis at a significant level of *P* \> 0.05. This was done in order to be able to assess and measure adherence at various levels of the population.

In our study, we compared skipping a dose of insulin to a normally prescribed insulin injection by the physician to the patient, with the reference to the non-skipping insulin dose. Patients who were prescribed number of 2 insulin dose are skipping 1-2, 2-4 and a 4-6 dose of insulin, and are respectively \[[Table 2](#T2){ref-type="table"}\] 0.778, 1.315 and 1.558 significantly times reduced compared to non-skipping insulin dose. \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison between skipped and non-skipped doses

  Variable                Sub variable   Skipped dose   Non skipped dose   *P*
  ----------------------- -------------- -------------- ------------------ ----------
  Gender                  Female         121            76                 0.994
                          Male           124            78                 
  Age                     14-29          25             48                 \<0.0001
  30-44                   36             24                                
  45-60                   99             57                                
  \>60                    85             25                                
  Education Level         Illiterate     105            44                 0.004
  Primary School          17             7                                 
  Secondary School        32             15                                
  High School             46             53                                
  College/university      43             33                                
  Post-Graduation Study   2              2                                 

###### 

Prevalence of adherence of diabetic patients to insulin injection

  Prevalence of adherence of diabetic patients to insulin injections                                                               
  -------------------------------------------------------------------- ---------------------------------- -------- ------- ------- ---------------------
  1-2 doses                                                            \[Number of Daily injections=2\]   -0.748   5.333   0.021   0.473 (0.251,0.893)
                                                                       \[Number of Daily injections=3\]   0.281    0.697   0.404   1.325 (0.685,2.564)
  2-4 doses                                                            \[Number of Daily injections=2\]   -1.315   9.167   0.002   0.268 (0.115,0.629)
                                                                       \[Number of Daily injections=3\]   0.174    0.204   0.651   1.19 (0.599,2.533)
  4-6 doses                                                            \[Number of Daily injections=2\]   -1.558   5.463   0.019   0.211 (0.057,0.778)
                                                                       \[Number of Daily injections=3\]   -0.341   0.31    0.577   0.711 (0.214,2.36)
  More than 6 dose                                                     \[Number of Daily injections=2\]   -0.105   0.033   0.855   0.901 (0.292,2.775)
                                                                       \[Number of Daily injections=3\]   0.488    0.596   0.44    1.63 (0.472,5.631)

Discussion {#sec1-4}
==========

Basal Bolus insulin is given to patients in order to mimic the body production of Insulin. Thus, appropriate insulin levels are maintained, and glucose is appropriately metabolized. Insulin therapy thus is dependent on the time injected, period of activity and the pre-prandial test to reflect insulin effect.\[[@ref13]\] Thus it is important to ensure that therapy levels are kept up for optimum therapy results.

Adherence of patients to basal bolus insulin therapy {#sec2-11}
----------------------------------------------------

Of the patients sampled, 61.90% of them reported to have not missed a dose, i.e. they are 100% in adherence with their prescriptions. Our results matched with Yarlagadda 2015 results\[[@ref12]\] which demonstrated in Ethiopia and reported 60% adherence in the given population. our finding is slightly lower than in a study by Rajagopalan *et al.*, who reported an adherence rate of 63% ± 24% in patients with insulin-treated type 2 diabetes,\[[@ref13]\] and slightly lower than that of Cramer *et al.*, who reported an adherence rate of 77% ± 17%.\[[@ref14]\]

Adherence differences among the sampled population {#sec2-12}
--------------------------------------------------

The gender influence on adherence is slightly diminished, as there are slightly similar adherence levels in male and female patients. 38.6% and 38.58% adherence, respectively. Our results matched with Geisel-Marbaise and Stummer (2010)\[[@ref17][@ref18][@ref19]\] who reported that regarding adherence rates, there is also no identifiable gender-related behaviour. Also, those noticing gender aspects often report neutrality respectively, showing a weak influence of gender on adherence behaviour.\[[@ref20][@ref21][@ref22][@ref23]\] Already in 1981, Dunn and Turtle came to the conclusion that there was no diabetic person. Salient are only the differing health beliefs of women who are more confident with physicians and medications in general.\[[@ref22][@ref24]\] Overall, there seems to be too little research on gender-related adherence to gain significant insights.

Age plays a prominent role. Though a previous study suggested that younger age was a possible factor tending towards non-adherence, this study is at variance with that position,

Our results show that poor levels of education has a negative impact on patient adherence. The solution is to advise them to keep reminders in order to keep to the prescriptions. These results matched with when adherence education was added to pharmacotherapy for 172 patients with uncontrolled diabetes.\[[@ref25]\] However, data from a comprehensive literature review suggested that such interventions did not improve adherence if it was already high.\[[@ref25]\] In a randomized trial, where patients received up to 10 telephone calls from their health educator at 4-6 week intervals over 1 year, there was a significant improvement in medication adherence for the patients. However, this intervention was not effective in those patients taking insulin.\[[@ref26]\] Newer methods to increase communication and relationships between patients and healthcare providers are being developed using resources such as electronic medical records and websites,\[[@ref27]\] and it is anticipated that these will result in improved medication adherence. An infographic showing the difference across education levels is shown in Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}, in the appendix.

![Education level of diabetic patients](JFMPC-8-1964-g002){#F2}

Factors affecting adherence to basal bolus insulin therapy {#sec2-13}
----------------------------------------------------------

Our study reported that Psychological and practical supports, Convenience of regimens and believe in efficacy of treatment are significant factors that affecting adherence to Basal Bolus Insulin therapy. An infographic showing various reasons for skipping doses and regimen is in Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}. Patients tend to have a well-defined dietary adaptation over the years which most are already used to. Changing such plans have shown to take several steps and counselling on the importance of the new modifications and why there is need for patients to adapt to it as fast as possible to have an effective diabetic control. Inappropriate timing, complex regimen, forgetting to take the doses among others are some of the principal influencing factors for adherence to therapy.

![Skipped doses and non-skipped doses against education level](JFMPC-8-1964-g003){#F3}

![Reason for not taking insulin injections](JFMPC-8-1964-g004){#F4}

In addition, studies have revealed that attachment to lifestyle modification plays an important role in diabetes control and nonadherence to lifestyle recommendations in patients with type 2 diabetes can affect the treatment outcome,\[[@ref28]\] which chimes in with the results of Mirahmadizadeh *et al.*, (2018)\[[@ref29]\] study in as much as the patients with a non-diabetic diet had a 2.38-fold increase in the likelihood of reluctance to use insulin. Such findings highlight the significant role of education of type 2 diabetes patients in relation to diet and other lifestyle changes. Moreover, they found a 6.75-fold increased chance of insulin initiation refusal among our illiterate patients, which emphasizes the need for designing simple and easy-to-understand educational materials for the illiterate diabetic population.\[[@ref28]\] As previous investigations have reported poor glycaemic control among diabetic patients, it is necessary that physicians pay greater attention to illiterate patients and bring to bear more patience in their education with a view to attaining favourable treatment results.\[[@ref30]\]

The other minor factors collected were described in terms of the patient\'s experiences in terms of complications. These included hypoglycemia, self-injection, fear of injections, running out of medications etc.

These barriers simply point to the fact that patients should be educated more, and should be closely monitored. The appointments intervals could be shortened for proper monitoring of the therapy outcomes and patient\'s adherence. For patients who are scared of the effects of hypoglycemia, it should be advised that they get glucometers, so they can monitor their blood sugar levels, and should be educated about the signs of hypoglycemia. Patients should be asked to fix their own convenient times for dosing, but the dose to be given, the extent of existing complications or otherwise, should be considered in setting dosing regimen. Psychological and practical support, patient belief in treatment efficacy, reduced number of injections are top factors, and recommended methods to increase adherence to insulin injection \[[Figure 4](#F4){ref-type="fig"}\].

Correlation of number of injections to skipping dose {#sec2-14}
----------------------------------------------------

Time-specific dosing can impact adherence and people may miss, reduce, or mistime insulin doses\[[@ref31]\] through eating habits and lifestyle, or recurrent hypoglycaemia or fear of hypoglycaemia.\[[@ref32]\] It is well documented that reduced adherence is associated with poorer glycaemic control, as measured by HbA~1c~,\[[@ref33]\] but little research has been published to explore the relationship between appropriate timing of insulin administration and glycaemic control.

From the results in [Table 3](#T3){ref-type="table"}, while reducing the number of injections may slightly increase adherence, we had compared the reasons for not taking your insulin injection, other reasons for missed doses, potential barriers that patients faced not to take insulin injections and difficulties faced during administering insulin injection, with skipping insulin dose amounts having an insignificant result. So, we could not identify any problem while we had compared barrier of factors increasing the adherence to insulin injections to how many amounts of skipping with the reference to minimize number of injections.

From [Table 4](#T4){ref-type="table"}, increasing adherence can be achieved by increasing regimen convenience, and helping the public gain confidence in medication use.

###### 

Factors increasing the adherence to insulin injections

  Factors increasing the adherence to insulin injections                                                      
  -------------------------------------------------------- ---------------------- ------- -------- ---------- ---------------------
  Psychological and practical supports                     How many missed Dose   0.568   31.366   \<0.0001   1.765 (1.447,2.153)
  Convenience of regimens                                  How many missed Dose   0.330   6.222    0.013      1.391 (1.073,1.804)
  Believe in efficacy of treatment                         How many missed Dose   0.759   42.620   \<0.0001   2.137 (1.701,2.684)
  Confidence of taking medications in public               How many missed Dose   0.035   0.021    0.885      1.036 (0.642,1.672)

a\. The reference category is: Minimize number of injections

Conclusion {#sec1-5}
==========

The basal bolus insulin therapy is very important in managing several types of diabetes. The levels of adherence across the patients' samples for this study is 61.09%. People who skip a dose of insulin 0.748 times compared to those who take 2 doses of insulin injection are more likely to adhere to their prescriptions. Literacy level and environmental factors (urban settlement) tend to have influence on level of adherence.

Since information and education are both vital as regards to adherence, the diabetic patients need psychological and practical support. They need to have convenient regimens and believe in the efficacy of the therapy more than minimizing the injections. It is important to also note that frequent clinic visits ensure effective monitoring of patient\'s adherences to the prescribed basal bolus insulin therapy. Shortcomings associated in the patient\'s adherences and proper counselling on the need for proper adherences will definitely improve patient\'s performance especially when we consider older patients that may be less informed in this information technology age.

Study strength {#sec2-15}
--------------

It is the first similar study which conducted in our area, included both genders with wide age range and spotted on different factors, which may affect insulin adherence.

Study limitations and recommendations {#sec2-16}
-------------------------------------

First, the relatively small sample size and single-centre design limits the generalization of our findings to the overall diabetic population. Second, our findings are based on cross-sectional data on self-reported medication adherence, which could have been biased by patients' foreknowledge of their laboratory results. Third, lack of data on adherence to the other aspects of diabetes, such as Body Mass Index (BMI) and physical activity, is another possible limitation, which otherwise would extend the knowledge obtained in the current study. Nevertheless, despite these certain limitations, given the paucity of the solid information on the subject, our findings represent a valuable contribution to the literature. Thus, future studies on higher population is recommended.
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